Home/Filings/4/0001104659-18-010410
4//SEC Filing

Schwabe Stefan K.F. 4

Accession 0001104659-18-010410

CIK 0001356576other

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 4:57 PM ET

Size

6.1 KB

Accession

0001104659-18-010410

Insider Transaction Report

Form 4
Period: 2018-02-14
Schwabe Stefan K.F.
Executive Vice President R&D
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2018-02-14+30,00030,000 total
    Exercise: $39.40Exp: 2028-02-14Common Stock (30,000 underlying)
Holdings
  • Common Stock

    1,967
Footnotes (2)
  • [F1]Includes an aggregate of 112 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan subsequent to the date of the Reporting Person's most recent filing on Form 4.
  • [F2]The option vests in four equal annual installments beginning on February 14, 2019.

Documents

1 file

Issuer

SUPERNUS PHARMACEUTICALS INC

CIK 0001356576

Entity typeother

Related Parties

1
  • filerCIK 0001557657

Filing Metadata

Form type
4
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 4:57 PM ET
Size
6.1 KB